|
1
|
Alexander S: Malignant fungating wounds:
Epidemiology, aetiology, presentation and assessment. J Wound Care.
18:273–274. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alvarez O, Kalinski C, Nusbaum J,
Hernandez L, Pappous E, Kyriannis C, Parker R, Chrzanowski G and
Comfort CP: Incorporating wound healing strategies to improve
palliation (symptom management) in patients with chronic wounds. J
Palliat Med. 10:1161–1189. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vardhan M, Flaminio Z, Sapru S, Tilley CP,
Fu MR, Comfort C, Li X and Saxena D: The microbiome, malignant
fungating wounds, and palliative care. Front Cell Infect Microbiol.
9:3732019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fromantin I, Seyer D, Watson S, Rollot F,
Elard J, Escande MC, De Rycke Y, Kriegel I and Larreta Garde V:
Bacterial floras and biofilms of malignant wounds associated with
breast cancers. J Clin Microbiol. 51:3368–3373. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Finlayson K, Teleni L and McCarthy AL:
Topical opioids and antimicrobials for the management of pain,
infection, and infection-related odors in malignant wounds: A
systematic review. Oncol Nurs Forum. 44:626–632. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mohs FE, Sevringhaus EL and Schmidt ER:
Conservative amputation of gangrenous parts by chemosurgery. Ann
Surg. 114:274–282. 1941. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mohs FE: Chemosurgical treatment of cancer
of the extremities and trunk; a microscopically controlled method
of excision. Arch Surg (1920). 57:818–832. 1948. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nemoto K, Okamoto M, Kito M, Aoki K,
Suzuki S, Takazawa A, Yoshimura Y and Kato H: Combined treatment
using Mohs' paste and neoadjuvant chemotherapy for giant gluteal
soft tissue sarcoma with malignant fungating wound: A case report.
J Surg Case Rep. 2019:rjz1372019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hoshi M, Iwai T, Oebisu N and Nakamura H:
Successful pre-operative local control of skin exposure by sarcoma
using combination of systemic chemotherapy and Mohs' chemosurgery.
World J Surg Oncol. 18:362020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bower M, Stein R, Evans TR, Hedley A, Pert
P and Coombes RC: A double-blind study of the efficacy of
metronidazole gel in the treatment of malodorous fungating tumours.
Eur J Cance. 28A:888–889. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kalinski C, Schnepf M, Laboy D, Hernandez
L, Nusbaum J, McGrinder B, Comfort C and Alvarez OM: Effectiveness
of a topical formulation containing metronidazole for wound odor
and exudate control. Wounds. 17:84–90. 2005.
|
|
12
|
Ashford R, Plant G, Maher J and Teare L:
Double-blind trial of metronidazole in malodorous ulcerating
tumours. Lancet. 1:1232–1233. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lutchminarian K and Clarke DL: The
microbiology of ulcerative skin cancers: Does the presence of
pathogenic bacteria increase the risk of postoperative
complications? S Afr J Surg. 59:25a–25e. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Elfallal AH, Laimon YN and Emile SH: Giant
angiolipoma of the back complicated with ulceration and sepsis:
Unusual presentation of a rare benign tumour. Ann R Coll Surg Engl.
101:e91–e93. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okajima K, Kobayashi H, Okuma T, Arai S,
Zhang L, Hirai T, Ishibashi Y, Ikegami M, Shinoda Y, Akiyama T, et
al: Prognosis and surgical outcome of soft tissue sarcoma with
malignant fungating wounds. Jpn J Clin Oncol. 51:78–84. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Potter BK, Adams SC, Qadir R, Pitcher JD
and Temple HT: Fungating soft-tissue sarcomas. Treatment
implications and prognostic importance of malignant ulceration. J
Bone Joint Surg Am. 91:567–574. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Parry M, Evans S, Sugath S, Wafa H, Jeys L
and Grimer R: Fungation in soft tissue sarcomas is associated with
poor survival. Int Orthop. 41:2613–2618. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hoshi M, Oebisu N, Iwai T, Ieguchi M and
Nakamura H: Clinical course of soft tissue sarcomas presenting as
malignant wounds. J Orthop Sci. 24:1088–1093. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fletcher CD, Bridge JA, Hogendoorn P and
Mertens F: WHO Classification of Tumours of soft tissue and bone.
4th edition. IARC Press; Lion: 2013
|
|
20
|
Guillou L, Coindre JM, Bonichon F, Nguyen
BB, Terrier P, Collin F, Vilain MO, Mandard AM, Le Doussal V,
Leroux A, et al: Comparative study of the National cancer institute
and french federation of cancer centers sarcoma group grading
systems in a population of 410 adult patients with soft tissue
sarcoma. J Clin Oncol. 15:350–362. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mangram AJ, Horan TC, Pearson ML, Silver
LC and Jarvis WR: Guideline for prevention of surgical site
infection, 1999. Hospital infection control practices advisory
committee. Infect Control Hosp Epidemiol. 20:250–278. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Egi M, Ogura H, Yatabe T, Atagi K, Inoue
S, Iba T, Kakihana Y, Kawasaki T, Kushimoto S, Kuroda Y, et al: The
Japanese clinical practice guidelines for management of sepsis and
septic shock 2020 (J-SSCG 2020). J Intensive Care. 9:532021.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rhodes A, Evans LE, Alhazzani W, Levy MM,
Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally
ME, et al: Surviving sepsis campaign: International guidelines for
management of sepsis and septic shock: 2016. Crit Care Med.
45:486–552. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Seymour CW, Liu VX, Iwashyna TJ,
Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM,
Shankar-Hari M, Singer M, et al: Assessment of Clinical criteria
for sepsis: For the Third International consensus definitions for
sepsis and septic shock (Sepsis-3). JAMA. 315:762–774. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pandharipande PP, Sanders N, Jacques P,
Ely EW and Shintani A: Calculating SOFA scores when arterial blood
gasses are not available: Validating
SpO2/FIO2 ratios for imputing
PaO2/FIO2 ratios in the SOFA scores. Crit
Care Med. 34:A12006. View Article : Google Scholar
|
|
26
|
Pasricha SR, Colman K, Centeno-Tablante E,
Garcia-Casal MN and Peña-Rosas JP: Revisiting WHO haemoglobin
thresholds to define anaemia in clinical medicine and public
health. Lancet Haematol. 5:e60–e62. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wittekind C, Compton C, Quirke P,
Nagtegaal I, Merkel S, Hermanek P and Sobin LH: A uniform residual
tumor (R) classification: Integration of the R classification and
the circumferential margin status. Cancer. 115:3483–3488. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zainul-Abidin S, Amanatullah DF, Anderson
MB, Austin M, Barretto JM, Battenberg A, Bedard NA, Bell K, Blevins
K, Callaghan JJ, et al: General assembly, prevention, host related
general: Proceedings of International consensus on orthopedic
infections. J Arthroplasty. 34:S13–S35. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chauveaux D: Preventing surgical-site
infections: Measures other than antibiotics. Orthop Traumatol Surg
Res. 101 (Suppl 1):S77–S83. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Korol E, Johnston K, Waser N, Sifakis F,
Jafri HS, Lo M and Kyaw MH: A systematic review of risk factors
associated with surgical site infections among surgical patients.
PLoS One. 8:e837432013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ramasubbu DA, Smith V, Hayden F and Cronin
P: Systemic antibiotics for treating malignant wounds. Cochrane
Database Syst Rev. Aug 24–2017.(Epu. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schierle CF, De la Garza M, Mustoe TA and
Galiano RD: Staphylococcal biofilms impair wound healing by
delaying reepithelialization in a murine cutaneous wound model.
Wound Repair Regen. 17:354–359. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Salisbury AM, Woo K, Sarkar S, Schultz G,
Malone M, Mayer DO and Percival SL: Tolerance of biofilms to
antimicrobials and significance to antibiotic resistance in wounds.
Surg Technol Int. 33:59–66. 2018.PubMed/NCBI
|
|
34
|
Hughes G and Webber MA: Novel approaches
to the treatment of bacterial biofilm infections. Br J Pharmacol.
174:2237–2246. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Villela-Castro DL, Santos VLCG and Woo K:
Polyhexanide versus metronidazole for odor management in malignant
(fungating) wounds: A double-blinded, randomized, clinical trial. J
Wound Ostomy Continence Nurs. 45:413–418. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Watanabe K, Shimo A, Tsugawa K, Tokuda Y,
Yamauchi H, Miyai E, Takemura K, Ikoma A and Nakamura S: Safe and
effective deodorization of malodorous fungating tumors using
topical metronidazole 0.75% gel (GK567): A multicenter, open-label,
phase III study (RDT.07.SRE.27013). Support Care Cancer.
24:2583–2590. 2016. View Article : Google Scholar : PubMed/NCBI
|
